Create a free Cannabis Equipment News account to continue

CBD Experts Pitch Congress on Fixes for Hemp Supply Chain Bottlenecks

"Policy solutions must address FDA concerns, protect states' rights, and meet the market where it is."

I Stock 1289885261
iStock

Charlotte's Web said CBD experts and advocates joined the ONE HEMP coalition in Washington DC this week to meet with members of Congress and their staff on Capitol Hill.

"The message of today's briefing was clear – the supply chain bottleneck caused by lack of regulation is negatively impacting millions of CBD consumers, farmers and manufacturers. ONE HEMP has provided sensible policy solutions backed by science to open a pathway for a safe, standardized CBD industry. Today was a critical step in our next goal to secure committee hearings with Energy & Commerce and Senate HELP," said Jared Stanley, co-founder and Chief Commercial Officer of Charlotte's Web.

During the briefing, Kelly D. Fair, Strategic Advisor and Legal Counsel to ONE HEMP, Dentons U.S. Cannabis and Hemp Group Partner, and organizer of ONE HEMP's RFI submission, outlined the policy recommendations saying, "Policy solutions must lead with science, address FDA concerns, protect states' rights, and meet the market where it is. Retailers want to sell CBD products and consumers want to access to them."

The panelists featured an authoritative, in-depth discussion on the current regulatory status of CBD and the best path forward by CBD industry experts and advocates including:

  • Jennifer Baxter, Executive Director, Balanced Veterans Network
  • Kelly Fair, Strategic Advisor, ONE HEMP and US Cannabis and Hemp Group Partner, Dentons
  • Paige Figi, Executive Director, Coalition for Access Now
  • Nicole Hemmenway, CEO, U.S. Pain Foundation
  • Dr. Rayetta Henderson, Foods & Consumer Products, Senior Managing Scientist, ToxStrategies LLC

The panelists spoke to the beneficial role that CBD plays in the lives of millions of Americans from all walks of life, along with key scientific and policy solutions for the future FDA regulation of CBD products as dietary supplements.

LISTEN IN: To watch a recording of the meeting, follow this link: 12-6-2023 ONE HEMP DC Briefing

The ONE HEMP briefing was part of a broader effort to urge the committees of jurisdiction in Congress – House Energy and Commerce and Senate "HELP" – to move ahead with marking up legislation. The nation's hemp and CBD producers, and the millions of Americans who rely on their products, will all benefit from a clear regulatory framework for CBD products. 

More in Manufacturing